Page last updated: 2024-10-28

haloperidol and Corneal Opacity

haloperidol has been researched along with Corneal Opacity in 1 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Corneal Opacity: Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakaya-Onishi, M1
Kiritoshi, A1
Hasegawa, T1
Watanabe, H1
Shimomura, Y1
Tano, Y1

Other Studies

1 other study available for haloperidol and Corneal Opacity

ArticleYear
Corneal endothelial cell loss after excimer laser keratectomy, associated with tranquilizers.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:10

    Topics: Benzodiazepines; Cell Count; Cell Size; Cornea; Corneal Opacity; Corneal Stroma; Endothelium, Cornea

1996